Lauren Santye, Assistant Editor

Patients who experienced side effects were 3 times more likely not to meet LDL cholesterol targets.

Cancer cells adjusted to have normal circadian rhythm slowed tumor growth.

Tumor growth can be fueled by sleep disruption.

More than half of adults with type 2 diabetes are unaware they are at an increased risk of heart disease.

The Iowa Department of Public Health released its first report on hepatitis C virus.

Extrachromosomal oncogene helps drive tumor evolution and heterogeneity.

The results showed all participants responded to omega-3 fatty acids to some degree, with a reduction in IgE production.

Statins among promising treatment options helping to progress the HIV treatment landscape.

Central nervous system lesions may impede cognitive and sensorimotor function in patients with MS.

Novel class of inhibitors may be used as a preventive measure for HIV in the future.

Lenalidomide (Revlimid) maintenance improved survival in multiple myeloma patients following a stem cell transplant.

Treatment with omega-3 reduces levels of IgE antibodies to reduce the risk of asthma flare-ups.

Tumors containing JAK1 and JAK2 mutations effect response to immunotherapy in patients with melanoma and colon cancer.

Top news of the day from across the health care landscape.

The second of a 2-part interview with National Association of Specialty Pharmacy President Rebecca Shanahan on the hottest issues in specialty pharmacy.

Physical activity drops during and after cancer treatment.

Potential drug may have a protective role in chronic obstructive pulmonary disease.

Anxiety and depression linked to longer time living with HIV.

Extensive psoriasis lesions remained in 18% of patients undergoing treatment.

Top news of the day from across the health care landscape.

NASP President Rebecca Shanahan discusses pressing topics in specialty pharmacy, including DIR fees and the potential impact of the Trump administration.

Few studies have examined the importance of socioeconomic risk factors on overall health.

New system could improve the implementation of pre-exposure prophylaxis-based care for HIV prevention.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how specialty pharmacy can best utilize data analytics.

New blood pressure genes may serve as potential drug targets for hypertension.

One round of investigational combination treatment may be more effective than long-term treatment for multiple sclerosis.

Efficacy of tocilizumab monotherapy was maintained or improved for up to 264 weeks.

Top news of the day from across the health care landscape.

Long-acting antiretroviral maintains significant viral load reduction and increases CD4+ T cells in HIV.

Flawed patents challenged on blockbuster HCV drugs to allow generic production.